1. Home
  2. BNED vs NGNE Comparison

BNED vs NGNE Comparison

Compare BNED & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barnes & Noble Education Inc

BNED

Barnes & Noble Education Inc

HOLD

Current Price

$8.69

Market Cap

311.3M

ML Signal

HOLD

Logo Neurogene Inc.

NGNE

Neurogene Inc.

HOLD

Current Price

$20.10

Market Cap

327.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNED
NGNE
Founded
1965
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
311.3M
327.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BNED
NGNE
Price
$8.69
$20.10
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$38.50
AVG Volume (30 Days)
551.4K
211.4K
Earning Date
09-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,567,800,000.00
N/A
Revenue This Year
$2.74
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.90
$6.88
52 Week High
$14.41
$37.27

Technical Indicators

Market Signals
Indicator
BNED
NGNE
Relative Strength Index (RSI) 50.93 40.03
Support Level $8.65 $19.65
Resistance Level $9.43 $21.97
Average True Range (ATR) 0.43 1.51
MACD 0.04 0.22
Stochastic Oscillator 16.74 17.77

Price Performance

Historical Comparison
BNED
NGNE

About BNED Barnes & Noble Education Inc

Barnes & Noble Education Inc is an operator of bookstores in college and university campuses across the United States. The company is also engaged in providing digital education services. It operates in three reportable segments that include Retail offers existing and prospective clients the flexibility of physical, virtual, or custom store solutions, and wholesale is comprised of the wholesale and virtual retail fulfillment, and support operations of the MBS subsidiary, also Corporate Services represent unallocated shared-service costs which include corporate level expenses and other governance functions, including executive functions, such as accounting, legal, treasury, information technology, and human resources. It earns majority of the revenue from Retail segment.

About NGNE Neurogene Inc.

Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.

Share on Social Networks: